CELCUITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CELCUITY INC. (CELC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 41.42 thousand shares for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2018-11-13
- CELCUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 20.27K shares, a 53.49% decline year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was 15.65K shares, a 89.16% decline year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-03-31 was 5.50K shares, a 46.67% increase year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-12-31 was 41.90K shares, a 194.04% increase year-over-year.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 233.63K shares, a 22.92% increase from fiscal 2016.
- CELCUITY INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 190.06K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2018-09-30 | 20.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 35.92K shares derived: sum of 2 quarters · filed 2018-11-13 | 41.42K shares 10-Q · filed 2018-11-13 | 83.32K shares derived: sum of 4 quarters · filed 2018-11-13 |
| 2018-06-30 | 15.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 21.15K shares 10-Q · filed 2018-08-09 | 63.05K shares derived: sum of 3 quarters · filed 2018-08-09 | 106.63K shares derived: sum of 4 quarters · filed 2018-11-13 |
| 2018-03-31 | 5.50K shares 10-Q · filed 2018-05-14 | 47.40K shares derived: sum of 2 quarters · filed 2018-05-14 | 90.98K shares derived: sum of 3 quarters · filed 2018-11-13 | 235.38K shares derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-12-31 | 41.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 85.48K shares derived: sum of 2 quarters · filed 2018-11-13 | 229.88K shares derived: sum of 3 quarters · filed 2018-11-13 | 233.63K shares 10-K · filed 2018-03-15 |
| 2017-09-30 | 43.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 187.98K shares derived: sum of 2 quarters · filed 2018-11-13 | 191.73K shares 10-Q · filed 2018-11-13 | 205.98K shares derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | 144.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 148.15K shares 10-Q · filed 2018-08-09 | 162.40K shares derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | 3.75K shares 10-Q · filed 2018-05-14 | 18.00K shares derived: sum of 2 quarters · filed 2018-05-14 | ||
| 2016-12-31 | 14.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 190.06K shares 10-K · filed 2018-03-15 | ||
| 2016-09-30 | 175.81K shares 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |